Literature DB >> 7884943

Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing.

D Hewlett, D L Horn, C Alfalla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7884943

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  28 in total

1.  pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia.

Authors:  H J Marttila; M Marjamäki; E Vyshnevskaya; B I Vyshnevskiy; T F Otten; A V Vasilyef; M K Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  M Mestdagh; P A Fonteyne; L Realini; R Rossau; G Jannes; W Mijs; K A De Smet; F Portaels; E Van den Eeckhout
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

3.  Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.

Authors:  Vívian de F Sumnienski Rodrigues; Maria Alice Telles; Marta Osório Ribeiro; Patrícia Izquierdo Cafrune; Maria Lucia Rosa Rossetti; Arnaldo Zaha
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Authors:  M M Hannan; E P Desmond; G P Morlock; G H Mazurek; J T Crawford
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.

Authors:  S J Cheng; L Thibert; T Sanchez; L Heifets; Y Zhang
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

6.  New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.

Authors:  L Heifets; T Sanchez
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 7.  The implications of whole-genome sequencing in the control of tuberculosis.

Authors:  Robyn S Lee; Marcel A Behr
Journal:  Ther Adv Infect Dis       Date:  2015-12-30

8.  Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.

Authors:  J Werngren; E Sturegård; P Juréen; K Ängeby; S Hoffner; T Schön
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

9.  Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.

Authors:  Muthuraj Muthaiah; Sridharan Jagadeesan; Nisha Ayalusamy; Manupriya Sreenivasan; Sambamurthy Sangamesvara Prabhu; Usharani Muthuraj; Kamatchiyammal Senthilkumar; Saroja Veerappan
Journal:  Int J Mol Sci       Date:  2010-07-07       Impact factor: 5.923

10.  Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatography.

Authors:  Amr M Mohamed; Dhundy R Bastola; Glenn P Morlock; Robert C Cooksey; Steven H Hinrichs
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.